Tiêu sợi huyết trong điều trị nhồi máu cơ tim cấp có đoạn st chênh lên ở người cao tuổi phần II
tải về 448.57 Kb.
|
TÀI LIỆU THAM KHẢO 1. Alexander KP et al. (2007) Acute coronary care in the elderly (part II), ST-segment elevation myocardial infarction: a statement for healthcare professionals from the American Heart Association Council of Clinical Cardiology, in collaboration with the Society of Geriatric Cardiology. Circulation (115), pp. 2570-2589. Al-Faleh H, Fu Y, Wagner G, et al (2006). Unraveling the spectrum of left bundle branch block in acute myocardial infarction: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT 2 and 3) trials. Am Heart J (151), pp. 10 - 15 . An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction (1993). The GUSTO Investigators. N Engl J Med (329), pp. 673-682. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS; DANAMI-2 Investigators (2003). A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med (349), pp. 733-742. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST- elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction. 2004). Available at: http://www.acc.org/clinical/guidelines/stemi/index.pdf. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC Jr (2008). 2007 focused update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction). J Am Coll Cardiol (51), pp. 210-47. Antman EM, Morrow DA, McCabe CH, Murphy SA, Ruda M, Sadowski Z, Budaj A, Lopez-Sendon JL, Guneri S, Jiang F, White HD, Fox KA, Braunwald E; ExTRACT-TIMI 25 Investigators (2006). Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med (354), pp.1477-1488. Assessment of the Safety and Efficacy of a New Thrombolytic Investigators (1999). Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet (354), pp. 716. Berger AK, Radford MJ, Wang Y, Krumholz HM (2000). Thrombolytic therapy in older patients. J Am Coll Cardiol (36), pp. 366-374. Berger AK, Schulman KA, Gersh BJ, Pirzada S, Breall JA, Johnson AE, Every NR (1999). Primary coronary angioplasty vs. thrombolysis for the management of acute myocardial infarction in elderly patients. JAMA (282), pp. 341-348. Bode C, Smalling RW, Berg G, et al (1996). Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators . Circulation (94), pp. 891. Boersma E, Maas AC, Deckers JW, Simoons ML (1996). Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet (348), pp. 771. Cannon C, Braunwald E (2008). Unstable Angina and Non-ST Elevation Myocardial Infarction. Braunwald's Heart Disease - A Textbook of Cardiovascular Medicine, 8th ed, pp. 1319-1344. Cannon CP , Gibson CM , McCabe CH, et al (1998). TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators . Circulation (98), pp. 2805 . 15. Cannon CP, McCabe CH, Gibson CM, et al (1997). TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. Circulation (95), pp. 351 . Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, Collins R, Liu LS; COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group (2005). Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebocontrolled trial. Lancet (366), pp. 1607-1621. Curtis JP, Alexander JH, Huang Y, et al (2004). Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-2 and -3). Am J Cardiol (94), pp. 279-83. Dauerman HL, Goldberg RJ, Malinski M, Yarzebski J, Lessard D, Gore JM (2001). Outcomes and early revascularization for elderly patients with acute myocardial infarction complicated by cardiogenic shock: a population based perspective. Am J Cardiol (87), pp. 844-848. Dauerman HL, Ryan TJ, Malenka DM, et al (2003). Outcomes of percutaneous coronary intervention among elderly patients in cardiogenic shock: a multi-center, decade long experience. J Inv Cardiol (15), pp. 380-384. de Boer MJ, Ottervanger JP, vant Hof AW, et al (2002). Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol (39), pp. 1723- 8. DeWood MA, Spores J, Hensley GR, et al (1983). Coronary arteriographic findings in acute transmural myocardial infarction. Circulation. Aug, 68 (2 Pt 2):I39-49. DeWood MA, Spores J, Notske R, et al (1980). Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. Oct 16, 303 (16), pp. 897-902. Dzavik V, Sleeper LA, Cocke TP, Moscucci M, Saucedo J, Hosat S, Jiang X, Slater J, LeJemtel TH, Hochman JS (2003). Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J (24), pp 828- 837. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo- controlled clinical trial. AIMS Trial Study Group (1988). Lancet (1), pp. 545-549. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Lancet 1986 (i), pp. 397 . Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction (2001). Lancet (358), pp. 605-613. Feit F, Breed J, Anderson JL, et al (1990). A randomized, placebo-controlled trial of tissue plasminogen activator in elderly patients with acute myocardial infarction (abstr). Circulation (82), Suppl III: III-666. Franzosi MG, Santoro E, De Vita C, et al (1998). Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 study. The GISSI Investigators . Circulation (98), pp. 2659 . Grines CL, Browne KF, Marco J, et al. (1993). A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med (328), pp. 673-9. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction (1990). Lancet (336), pp. 65. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH (1999). Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock? N Engl J Med (341), pp. 625-634. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists (FTT) Collaborative Group (1994). Lancet (343), pp. 311-322. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 (1998). Lancet (ii), pp. 349. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction (1992). Lancet (339), pp. 753. 35. Ito H, Maruyama A, Iwakura K, et al (1996). Clinical implications of the no reflow phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation (93), pp.223 . Juhlin P, Bostrom PA, Torp A, Bredberg A (1999). Streptokinase antibodies inhibit reperfusion during thrombolytic therapy with streptokinase in acute myocardial infarction. J Intern Med (245), pp.483 . Keeley EC, Boura JA, Grines CL (2003). Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet (361), pp. 13-20. Krumholz HM, Pasternak RC, Weinstein MC, Friesinger GC, Ridker PM, Tosteson AN, Goldman L (1992). Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med (327), pp. 7-13. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction (1993). Lancet (342), pp. 759-766. Liebson PR, Klein LW (1997). The non-Q wave myocardial infarction revisited: 10 years later. Prog Cardiovasc Dis. Mar-Apr; 39 (5), pp. 399-444. Maan Jokhadar and Nanette K Wenger (2009). Review of the treatment of acute coronary syndrome in elderly patients. Clinical Interventions in Aging (4) pp. 435-444. Matthew Daka, Emad Aziz, Robert Leber, and Mun K. Hong (2008). Diagnosis and Treatment of ST-Segment Elevation Myocardial Infarction. In Acute Coronary Syndrome- Multidisciplinary and Pathway-Based Approach, Springer-Verlag London Limited, pp. 48-59. Peter R Sinnaeve and Frans J Van de Werf (2008). Fibrinolytics: current indications and treatment modalities in the absence of mechanical reperfusion. In Clinical Guide to the Use of Antithrombotic Drugs in Coronary Artery Disease, pp. 163-176. Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. EMERAS (Estudio Multicntrico Estreptoquinasa Repblicas de Amrica del Sur) Collaborative Group (1993). Lancet (342), pp. 767- 772. Rich MW (2003). Thrombolytic therapy is indicated for patients over 75 years of age with ST-elevation acute myocardial infarction: protagonist viewpoint. Am J Geriatr Cardiol (12), pp. 344-347. Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill KA, Skene AM, McCabe CH, Braunwald E; CLARITY-TIMI 28 Investigators (2005). Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med (352), pp. 1179 -1183. SHOCK Investigators (2001). One-year survival following early revascularization for cardiogenic shock. JAMA (285), pp. 190-192. Simes RJ , Topol EJ , Holmes DR Jr, et al (1995). Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators . Circulation (91), pp. 1923. Sinnaeve P, Alexander J, Belmans A, et al (2003). One-year follow-up of the ASSENT-2 trial: a double-blind, randomized comparison of singlebolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acute myocardial infarction. Am Heart J (146), pp. 27. Smalling RW, Bode C, Kalbfleisch J, et al (1995). More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators. Circulation ( 91), pp. 2725. Stenestrand U, Wallentin L (2003). Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohort. Arch Intern Med (163), pp. 965-971. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators (1997). A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med (337), pp. 1118 . The GUSTO investigators (1993). An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med (329), pp. 673. The GUSTO-IIb Investigators (1997). A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med (336), pp. 1621- 8. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS): Guidelines on myocardial revascularization (2010). Eur Heart J (31), pp. 2501-2555. The task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology: Management of acute myocardial infarction in patients presenting with persistent ST-Segment elevation (2008). Eur Heart J (29), pp. 2909-45. 56. Angela L. Brown, Anne C. Goldberg, Katherine E.Henderson, Kory Lavine, Andrew Kates, Nevine F. Mistry. ST-segment Elavation Myocardial Infarction, Preventive Cardiology and Ischemic Heart Disease, Chapter 4, p 128- 154, The Washington Manual of Medicine Therapeutics, 33rd Edition, 2010, Department of Medicine, Washington University School of Medicine 57. Thiemann DR, Coresh J, Schulman SP, Gerstenblith G, Oetgen WJ, Powe NR (2000). Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation (101), pp. 2239-2246. Thune JJ, Hoefsten DE, Lindholm MG, Mortensen LS, Andersen HR, Nielsen TT, Kober L, Kelbaek H; Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI)-2 Investigators (2005). Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty. Circulation (112), pp. 2017-2021. Thygesen K, Alpert JS, White HD, et al (2007). Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Eur Heart J. Oct 28 (20) pp. 2525-2538. Topol EJ (2000). Acute myocardial infarction: thrombolysis. Heart (83), pp.122 . Topol EJ (2001). Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomized trial. Lancet (357), pp. 1905-1914. Topol EJ, Ohman EM, Armstrong PW, et al (2000). Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III trial. Circulation (102), pp. 1761 . van de Werf FJ, Ardissino D, Betriu A, et al (2003). Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J (24), pp. 28 . van de Werf FJ, Barron HV, Armstrong PW, et al (2001). Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA. Eur Heart J (22), pp. 2253 . Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM (2000). Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol ( 20), pp. 1262-75. Wallentin L, Goldstein P, Armstrong PW, Granger CB, Adgey AA, Arntz H.R, Bogaerts K, Danays T, Lindahl B, Makijarvi M, Verheugt F, Van de Werf F (2003). Efficacy and safety of tenecteplase in combination with the low- molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation (108), pp. 135-142. White HD (2000). Thrombolytic therapy in the elderly. Lancet (356), pp. 2028-2030. Yerem Yeghiazarians, Joel B. Braunstein, Arman Askari, and Peter H. Stone (2000). Unstable Angina Pectoris. N Engl J Med 2000 (342), pp.101-114. Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, Budaj A, Peters RJ, Bassand JP, Wallentin L, Joyner C, Fox KA; OASIS-6 Trial Group (2006). Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 Randomized Trial. JAMA (295), pp. 1519- 1530. Zahn R, Schiele R, Schneider S, Gitt AK, Wienberger H, Seidl K, Voigtlander T, Gottwik M, Berg G, Altman E, Rosahl W, Senges J (2001). Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal . Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction Registry. J Am Coll Cardiol (37), pp. 1827- 1835. Zijlstra F, Patel A, Jones M, et al (2002). Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J (23), pp. 550 -7. Каталог: download -> version -> 1407572794 -> module -> 6305562181 -> name version -> CÁc hàm thông dụng các hàm tóan học (math & trig) version -> ĐỀ CƯƠng kt hoc ky 1 khốI 10 2013-2014 version -> CHƯƠng II: TỔng quan về ĐẦu tư quốc tế Khái niệm và đặc điểm của đầu tư quốc tế version -> BÊn thắng cuộC – chưƠng III: ĐÁnh tư SẢN version -> Nhà Tây Sơn version -> United States of America Hợp chúng quốc Hoa Kỳ version -> Hiệp hội các Quốc gia Đông Nam Á tiếng Anh: Association of Southeast Asia Nations, viết tắt là asean version -> BÊn thắng cuộC – chưƠng IX: XÉ RÀO name -> Tiêu sợi huyết trong điều trị nhồi máu cơ tim cấp có đoạn st chênh lên ở người cao tuổi phần II tải về 448.57 Kb. Chia sẻ với bạn bè của bạn:
|